MMP9 and endometriosis: Recently, it was demonstrated in mice that the treatment of 15-Epi-lipoxin A4 (LXA4) may inhibit the progression of endometriosis possibly by lowering the concentrations and the activities of MMP-2 and MMP-9 [38].